Shares of Smith & Nephew plc (LON:SN – Get Free Report) have been assigned an average rating of “Hold” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is GBX 1,310.
Several analysts recently commented on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,500 target price on shares of Smith & Nephew in a report on Wednesday, August 5th. JPMorgan Chase & Co. lowered their price objective on Smith & Nephew from GBX 1,438 to GBX 1,290 and set a “neutral” rating on the stock in a research report on Thursday, August 6th. Berenberg Bank dropped their price objective on shares of Smith & Nephew from GBX 1,300 to GBX 1,250 and set a “hold” rating on the stock in a research note on Friday, August 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a GBX 1,400 target price on shares of Smith & Nephew in a report on Thursday, July 30th. Finally, Shore Capital Group reiterated a “buy” rating and issued a GBX 1,000 target price on shares of Smith & Nephew in a research note on Tuesday, July 21st.
Read Our Latest Stock Analysis on Smith & Nephew
Smith & Nephew Stock Down 0.4%
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
See Also
- Five stocks we like better than Smith & Nephew
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
